• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
James Paton

Stay informed with James Paton’s coverage and analysis.

GSK’s new vaccine hire looks beyond COVID in quest for next hit: ‘The potential is there to really make a much better flu vaccine’
Health
GSK’s new vaccine hire looks beyond COVID in quest for next hit: ‘The potential is there to really make a much better flu vaccine’
By James Paton and BloombergJuly 3, 2022
A health worker prepares the Pfizer vaccine
Health
Failure to address a global surplus of COVID vaccines raises the risk of new variants emerging, health experts warn
By Josh Wingrove, James Paton, Antony Sguazzin and BloombergMay 11, 2022
Pfizer COVID-19 vaccine
Health
U.K. to offer Pfizer COVID vaccine to children ages 5 to 11
By James Paton, Deirdre Hipwell and BloombergFebruary 16, 2022
Moderna chair says COVID could become flu-like endemic in 2022
Health
Moderna chair says COVID could become flu-like endemic in 2022
By James Paton and BloombergJanuary 14, 2022
COVID-19 cases surge in schools as U.K. waits to offer vaccines to adolescents
Health
COVID-19 cases surge in schools as U.K. waits to offer vaccines to adolescents
By Suzi Ring, James Paton and BloombergOctober 19, 2021
Merck & Co. headquarters in Kenilworth, N.J.
Health
Rich countries’ rush to buy Merck antiviral pill risks leaving poor countries behind in COVID fight—again
By James Paton and BloombergOctober 12, 2021
World Health Organization backs first Malaria vaccine for at-risk children
Health
World Health Organization backs first Malaria vaccine for at-risk children
By James Paton, Joel Leon and BloombergOctober 6, 2021
Global COVID vaccine program Covax falls short of its distribution target
Health
Global COVID vaccine program Covax falls short of its distribution target
By James Paton and BloombergSeptember 8, 2021
Rich countries will soon have over 1 billion COVID vaccine doses they don’t need
Health
Rich countries will soon have over 1 billion COVID vaccine doses they don’t need
By James Paton and BloombergSeptember 6, 2021
AC Immune shares surge on Alzheimer’s drug trial results
Health
AC Immune shares surge on Alzheimer’s drug trial results
By Naomi Kresge, James Paton and BloombergAugust 31, 2021
How COVID-19 came raging back in 2021
Health
How COVID-19 came raging back in 2021
By James Paton, Robert Langreth and BloombergJuly 27, 2021
China is filling the global COVID vaccine shortage left by the U.S. and India
Health
China is filling the global COVID vaccine shortage left by the U.S. and India
By Iain Marlow, Sudhi Ranjan Sen, James Paton and BloombergMay 7, 2021
COVID-19 Vaccine Rollout Begins On Boigu Island
Health
AstraZeneca revises vaccine efficacy down to 76% after criticism of U.S. trial data
By James Paton, Michelle Fay Cortez and BloombergMarch 24, 2021
GlaxoSmithKline gets rid of Trump’s vaccine adviser Slaoui for sexual harassment
Leadership
GlaxoSmithKline gets rid of Trump’s vaccine adviser Slaoui for sexual harassment
By James Paton, Riley Griffin and BloombergMarch 24, 2021
University of Oxford finds AstraZeneca vaccine effective on British variant
Health
University of Oxford finds AstraZeneca vaccine effective on British variant
By Eric Pfanner, James Paton and BloombergFebruary 5, 2021
1
  • 1
  • 2
  • 3
3
Most Popular
Success
MacKenzie Scott alone accounted for one-third of America's $19.2 billion in megagifts last yearplaceholder alt text
By Sydney LakeJune 25, 2026
Big Tech
As Big Tech showers employees with perks to win the talent war, Nvidia built a nearly $5 trillion company by making people pay for their own lunchplaceholder alt text
By Marco Quiroz-GutierrezJuly 1, 2026
Success
Philanthropy leader at Warren Buffett and Bill Gates’ Giving Pledge says children of billionaires are pushing them to give their wealth away fasterplaceholder alt text
By Preston ForeJune 27, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.